chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No fever. Child woke with "spots" on forehead (R) side and ant. neck and temple on 070707. More spots on 0712/07. Mother took child to doctor on 0712/07. TC from doctors office AM 0713/07 with above info. MD not sure if reaction from vaccines. TC to CDNS. Call mother to fill out VAERS and received more info. Mother state day 071307that spots have not increased. Denies any blisters> denies any fever. Mother states spots are barely raised.
Dizziness, occasionally severe, and chronic fatigue beginning Saturday morning, 3/6/2021, and continuing unabated thru Tuesday, 3/9/2021.  Currently on bedrest.  This condition is ongoing.
Resident developed low grade fever next day and it continued through Monday morning with some mottling starting to appear on resident's skin.  Sent to ER on Monday.  Resident sent to higher level of care and diagnosed with pneumonia and bilateral pulmonary embolism
when I went to bed On March 29 at 9pm I noticed the ringing in both ears it is worrisome to have something like this to start so abruptly. I used to listen to TV on a volume of 25 and now I must turn the volume to 35 to understand what is being said. The ear ringing did not stop so I went to see an ENT doctor on 05/05/2021 for an exam plus they gave me a hearing test and referred me to clinic. On May 14th around 9pm I had bursts of severe pain in my left ear and then in the right ear but not nearly as severe my ears continue to have a low level of discomfort off and on. I also had bursts of headaches a few days later. I am signed up for workshops thru Clinic on May 26,2021 they are offering them online because they have had an exorbitant increase in patients which is also concerning to me. I have an appointment with the Clinic July 12,2021.
7/3/2012 AM fever of ~101 throughout the dat (treated with ibuprofen). 7/4/2012 AM hives all over body for most of the day, repeated treatment with oral Benadryl and topical hydrocortisone.
20 WEEK GESTATION BECAME FAINTY WITHIN 15 MINUTES OF INJECTION, B/P 112/72
began to have slight pain to right side of face intermit, then became constant, then 3 days ago noted right eye is more closed and muscles to right side of face are drooping slightly sensation to side of face feels the same as when had onset of Bells Palsy in 2003
sore arm after first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm after first dose) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A,) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL + HIDROCLOROTIAZIDA), FERROUS SULFATE and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm after first dose). At the time of the report, PAIN IN EXTREMITY (sore arm after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pt recvd vax in 1985 & recvd 2nd inject 3MAR92 & 9MAR92 devel a sudden onset arthritis of the ankle joint manifested by pain, swelling, redness, warmth, & considerable tenderness; 10MAR92 pt presented to MD; CBC, ESR, x-ray were all nl;
August 6, patient fell getting out of bed and hit right side arm/hip on door.   No head impact August 9, patient at ER with confusion, CT scan of brain normal August 10, patient at ER again with stroke like symptons, non-verbal, confusion, extreme headache.  Admitted to hospital for 3 days August 27, patient has extreme pain in lower left leg, after ultrasound blood clot both acute and chronic found in leg.   Lung scan also showing blood clots.   Patient admitted and put on Heparin for 48 hours
Vaccines administered on 07-31-18 at 11:20am. Infant was at the babysitters that night and was noted to be very fussy and sleepy. Slept for three hours. At 10pm when mother returned home with infant she removed his sleeper and noted a large red raised hive on his right arm. Mother states the hive covered most of his arm. Infant had a low grade fever of 101.1. Acetaminophen given. Mother monitored infant closely thru out the night. Mother then noticed the large hive on left arm and the right arm hive faded. This then progressed to left side of face and forehead and then to right side of face and forehead with the left side faded. This lasted for approximately 24 hours. Then for the next 4-5 days mother noted smaller red raised hives over arms and legs and face that would be present and then fade away. Infant ran a low grade fever for 3 days which was controlled with Acetaminophen. Mother contacted family Dr, on 08/02/18. Doctor ordered ZRYTEC for infant once daily. Mom states the rash improved each day infant took ZRYTEC and only had to take the ZRYTEC for 3days before the rash was gone.
It was reported that this pt inadvertently received two doses of vax on 9/21/98 one hour apart. No adverse reactions occurred and the pt reportedly recovered from this experience.
Patient originally presented the day a day prior to Emergency Department for epigastric pain and after a thorough workup diagnosed with COVID-19. She had shortness of breath at this  myalgia cough, with pain in epigastric area.  Of inset was 3 days with loose stools without blood.  A flat and upright of the abdomen complete with a PA of the chest was obtained and was read and reported to suggests  acute abdominal abnormality with moderate bilateral pneumonia consistent with COVID-19 disease. CT of the chest, abdomen, and pelvis without contrast showed: Scattered groundglass opacities are seen in the bilateral lung fields. Findings are concerning for multifocal pneumonia/viral pneumonia.    Patient was admitted for Acute Hypoxic Respiratory Failure 2/2 Covid 19 Pneumonia. Patient has been treated for covid 19 pneumona. Has received dexamethasone, remdesivir 6mg.
Complained of pain, redness and swelling at injection site; some itching at site also.  Redness and swelling size of silver dollar.  Is taking Tylenol and Benadryl.  To put ice on site also.
Vaccine administered past BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered past BUD) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C2A1) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered past BUD). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered past BUD) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant products were reported by the reporter. Upon internal review on 04-Aug-2021, the age was corrected to 18 years.
My all organic face products, which haven?t changed and I?ve never had an adverse reaction to, started feeling like a chemical burn on the same night as the vaccine. It has continued to feel like that, although the severity has subsided. Within a couple of days, I started having a random feeling of swelling all along my jawline, and noticed a bright red, hot, itchy rash along the jawline and upper neck area. It wasn?t raised or bumpy.  I now get random reactions like that throughout the day, and it has changed from being jawline/upper neck-specific to random areas of the neck.
No adverse event; dose was administered 12-hour after puncturing the vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was administered 12-hour after puncturing the vial) and NO ADVERSE EVENT (No adverse event) in a 6-month-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1417B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Dec-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was administered 12-hour after puncturing the vial). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose was administered 12-hour after puncturing the vial) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (dose was administered 12-hour after puncturing the vial).    No concomitant medications were reported.  The information was unknown whether patient had received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  The HCP stated that a patient received Moderna vaccine for 6m-5y in morning on 22-Dec-2022 around 11 AM. The dose was administered 12-hour after puncturing the vial. The patient and parents were aware and did not report any side effects, but it only just happened 2 hours ago.  No treatment medications were reported.
Body aches; fever; This case was reported by a pharmacist via call center representative and described the occurrence of general body pain in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Concurrent medical conditions included methicillin-resistant staphylococcus aureus infection (carrier for MERSA).   On 13th May 2019, the patient received Shingrix and Boostrix. On 13th May 2019, several hours after receiving Shingrix and Boostrix, the patient experienced general body pain and fever. On an unknown date, the outcome of the general body pain and fever were unknown.   It was unknown if the reporter considered the general body pain and fever to be related to Shingrix and Boostrix.  Additional details were provided as follows: On 13th May 2019, both the Shingrix and Boostrix were administered at the same time and few hours later the patient experienced a fever and body aches. The clinical pharmacist was unaware if symptoms subsided.  The patient was carrier for Methicillin-resistant Staphylococcus aureus infection. The health care professional would like to know if medical information had information to share with the patient. The health care professional did not provide lot number and expiration dates.
This spontaneous report was received from a health care professional refers to an approximately 20 years old female patient. Medical history and allergies were none. On an unspecified date in 1995 the patient was vaccinated with first dose of VARIVAX (Merck) (dose, route, frequency and lot # unspecified). On an unspecified date in 2008 the patient was vaccinated with second dose of VARIVAX (Merck) (dose, route, frequency and lot # unspecified). No concomitant medications were reported. It was reported that the result of an unspecified blood test was negative immunity to chickenpox on an unspecified date about two weeks ago in June 2015 (antibody test negative). Patient sought medical attention by visiting pharmacy and speaking to healthcare professional on 25-JUN-2015. The outcome of antibody test negative was unknown. Causality assessment as not reported. Additional information has been requested.
I caught COVID-19. It started with dry throat. Nothing I drunk worked. Then the next day it was a little bit worse.  I started to get a headache then fatigue and dizziness started to hit. The fatigue and the sore throat was the worse part of it. On the 4th day, I return home from a flight. I started taking zinc and my vitamins. I noticed my ears started hurting as well. That night, my temperature got to 104. I took some ibuprofen and it went down to 101. On day 5, Your doctor arrive at my house, The doctor diagnosed me with an ear infection and COVID-19. I was prescribed amoxicillin for the ear infection. I took Benzonatate for my  sore throat and coughing. I also took prednisone. I was also given an inhaler.
THERE WAS ACTULLY NO ADVERSE EVENT. THE REASON THIS IS BEING REPORTED IS BECAUSE THE PATIENT RECEIVED THE VACCINE, BUT THE PATIENT IS UNDER THE AGE OF 18.
Started with bloody nose, 3x on 11/16/21, on 11/18/21 broke out on the legs with HSP rash(Henoch-Schonlein purpura) and continued with bloody noses. Was seen by PCP and  labs were drawn on 11/18/21 all were negative. Was seen again 11/24/21, blood pressure and urine was fine.   Has a follow up again scheduled for 12/1/21. Child continues with rash and occasional bloody noses.
Pt recvd vax 3APR92 @ 1430 hrs, given APAP @ 1600 hrs; t103.8 R @ 1830hrs; generalized edeam noted 1930hrs, w/shallow rapid breathing, DTP inject site red,swollen; fever resolved 6APR92, edema resolved 5APR92; phone contact w/MD;
On 3/04/2021, patient experienced a seizure. It was an isolated incident and lasted less than a minute. There did not seem to be any residual effects.  This was the first and only incidence of a seizure in patient.  On 2/27/21 patient experienced fever of 100.8 , exhaustion and delirium. On 2/28/21, temperature was 99.9 and patient slept most of the day. He was restless and cried out in his sleep,  speaking to people who were not present.    On 3/1/21 temperature was normal and patient was tired but otherwise non symptomatic.
Felt a rush of chest heaviness x 1-2 minutes that resolved, increased BP and right wrist swelling
Knot in inject site - note: both vaccines were given in same site - left leg. PT was instructed to go to ER 2 days later when her mother reported the Rxn. Was in ER for 30 mins and released.
Slight redness at injection site. Swelling at injection site about the size of a lemon. Itchiness and puffiness underneath eyes. Vaccine administered 10/21/14 to right arm.
SYNCOPAL EPISODE ~2 MINUTES POST INJECTION, TEMPORARY LOSS OF VISION, HEARING  VITALS: SP02: 97% PULSE: 90 BP: 122/58 GCS: 15
First signs of reaction on 01/05/2018, reason for office visit, fever at 10:15 am. Fever reading 101.7F. Weight 27.8 lbs. 01/06/2018, reason for emergency nurse triage visit, rash (Rosela) at 18:48:59. 01/08/2018 emergency/admission to hospital. Noted on 01/08/2018 Atypical Kawasaki disease.
At 1623 patient reports itchiness all over face, tingling to jaw line & right eye twitching. BP 109/76, P 77, R 20, SpO2 100%.  At 1628 pt. examined by NP, reporting no redness/swelling to throat and lungs clear upon auscultation.  Pt. given oral solution of Benadryl 25 mg along with water to drink. Reports increase to itchiness to face.  At 1640 Reports itchiness only along jaw line with the  other symptoms resolved.  BP 111/76, P 80, R 20, SpO2 98%.  At 1643 patient states able to drive home.
Real sore/ painful; Patch under her breast/pea shaped; Red in that area/red around the area; A cluster of three of them; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Real sore/ painful), RASH (Patch under her breast/pea shaped), ERYTHEMA (Red in that area/red around the area) and ADVERSE REACTION (A cluster of three of them) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A0LA) for COVID-19 vaccination.     Concurrent medical conditions included Allergy. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Real sore/ painful), RASH (Patch under her breast/pea shaped), ERYTHEMA (Red in that area/red around the area) and ADVERSE REACTION (A cluster of three of them). The patient was treated with TRIAMCINOLONE at an unspecified dose and frequency. At the time of the report, PAIN (Real sore/ painful), RASH (Patch under her breast/pea shaped), ERYTHEMA (Red in that area/red around the area) and ADVERSE REACTION (A cluster of three of them) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
felt like his eyes were burning from the inside out and lasted 3 days.  Patient did not seek treatment
Progressively severe headache combined with nausea. Threw up once. Mostly resolved by next day aside from lingering headache.
High fever and chills (102) for first 24 hours, 100 for next 24 hours, full body muscle pain, fatigue, headache, nausea, arm and leg numbness, muscle spasms, ringing in ears. Fever broke after 48 hours, other symptoms continued for three more days so far.
Erythema, tenderness, warmth at site of injection; low grade temp 99.2 - Rx cephalexin x 7d.
Palpitations and tremors of both hands followed by tingling of patient's tongue within 5 minutes of receiving the vaccine.  Patient states her palpitations and tremors lasted about 15 minutes and spontaneously resolved. However, her tongue tingling lasted until she took Benadryl about an hour after onset of her symptoms. Patient denies tongue or lip swelling or throat tightening sensation.
Pt presented to the pharmacy on 3/2/2019 with burning pain in his upper left arm, shoulder and back. He describes a burning pain along with a tingle that goes down to his fingers. Also, numbness of fingers, decreased arm strength, and tremor of the left hand. The symptoms started around 6 days after receiving the vaccine. It has not gone away as he expected and has gotten worse.
Heart felt like it was coming out of her chest all day then it went away; felt as if she was about to die; Had a fever of 99.8°F/Keeping a low grade temperature; Felt odd; little sluggish; Slept from 12:00 noon-10:30 pm; Really didn't feel well; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt odd), SLUGGISHNESS (little sluggish), SOMNOLENCE (Slept from 12:00 noon-10:30 pm), MALAISE (Really didn't feel well) and CHEST DISCOMFORT (Heart felt like it was coming out of her chest all day then it went away) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Sep-2021, the patient experienced FEELING ABNORMAL (Felt odd), SLUGGISHNESS (little sluggish), SOMNOLENCE (Slept from 12:00 noon-10:30 pm), MALAISE (Really didn't feel well) and PYREXIA (Had a fever of 99.8°F/Keeping a low grade temperature). On 10-Sep-2021, the patient experienced CHEST DISCOMFORT (Heart felt like it was coming out of her chest all day then it went away) and FEELING ABNORMAL (felt as if she was about to die). At the time of the report, FEELING ABNORMAL (Felt odd), SLUGGISHNESS (little sluggish), SOMNOLENCE (Slept from 12:00 noon-10:30 pm), MALAISE (Really didn't feel well), FEELING ABNORMAL (felt as if she was about to die) and PYREXIA (Had a fever of 99.8°F/Keeping a low grade temperature) was resolving and CHEST DISCOMFORT (Heart felt like it was coming out of her chest all day then it went away) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Sep-2021, Body temperature: 99.8°f (High) low grade temperature.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
1st dose 2019, 2nd dose on 24Jan2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 69-year-old male patient who received Herpes zoster (Shingrix) (batch number G4PY5, expiry date 15th April 2023) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 29th September 2019).   On 24th January 2022, the patient received the 2nd dose of Shingrix. On 24th January 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The patient received a late 2nd dose of Shingrix, which led to lengthening of vaccination schedule. The reporter consented to follow up. The reporter did not have the lot/expiry of the 1st dose.
Sore throat, congestion, runny nose, sneezing, headache, chills, sweats, fever, brain fog
BREAKTHROUGH COVID INFECTION. PATIENT TESTED POSITIVE ON 10/24/2021. PATIENT FULLY VACCINATED ON 08/03/2021.
Red area, hot to touch, painful, treatment: DEPO-MEDROL, ZYRTEC.
involved in a fender bender car accident; The pateint missed the second dose; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program, Pfizer.. An 88-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 02Mar2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 21Mar2021, the patient was involved in a fender bender car accident. The patient stated it had nothing to do with the vaccine. The patient missed the second dose on 23Mar2021. The patient stated she read that as long as she got it within 6 weeks she did not have to get the second dose, she stated it has now been 8 weeks since first shot. The patient was hospitalized on 21Mar2021 and was discharged in Mid Apr2021. The outcome of the event was unknown.  Information on the batch number has been requested.; Sender's Comments: Based on the current available information, the event  Automobile accident  is most likely related to an intercurrent condition which is not related to the suspected drug. The case will be reassessed if additional information becomes available.  ,Linked Report(s) : US-PFIZER INC-2021497247 same reporter, vaccine, events, different patients
Fifteen minutes after injection client complained of generalized itching at injection site.  Denied respiratory distress of SOB.  Took benadryl.  Primary physician notified and client driven by co-worker to physician office.
On 23MAR92 devel vesicular rxn @ site of inject w/induration; seen in office next AM w/urticarial plaques 8.5 x 6 cm @ sit e & distal
This case was reported by a healthcare professional and described the occurrence of hives in a 57-year-old male subject who was vaccinated with Twinrix (GlaxoSmithKline) for prophylaxis. On 11 September 2007 the subject received 1st dose of Twinrix (unknown). On 22 October 2007, 41 days after vaccination with Twinrix, the subject, who is an international pilot, and was at 35,000 feet, developed hives. They were mainly on his trunk. The pilot was grounded from flying at that point and was given Benadryl for treatment. The healthcare professional considered the events were disabling and clinically significant (or requiring intervention). It was reported that the hives/rash had improved and were almost resolved. The healthcare professional considered the event of hives was possibly related to vaccination with Twinrix.